224 related articles for article (PubMed ID: 36797289)
1. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.
Li JY; Zhao Y; Gong S; Wang MM; Liu X; He QM; Li YQ; Huang SY; Qiao H; Tan XR; Ye ML; Zhu XH; He SW; Li Q; Liang YL; Chen KL; Huang SW; Li QJ; Ma J; Liu N
Nat Commun; 2023 Feb; 14(1):865. PubMed ID: 36797289
[TBL] [Abstract][Full Text] [Related]
2. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma.
Chen Y; Zhao Y; Yang X; Ren X; Huang S; Gong S; Tan X; Li J; He S; Li Y; Hong X; Li Q; Ding C; Fang X; Ma J; Liu N
Nat Commun; 2022 Jan; 13(1):501. PubMed ID: 35079021
[TBL] [Abstract][Full Text] [Related]
3. TRIM21-SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis.
Zhang P; Li X; He Q; Zhang L; Song K; Yang X; He Q; Wang Y; Hong X; Ma J; Liu N
J Biomed Sci; 2020 Jan; 27(1):30. PubMed ID: 32005234
[TBL] [Abstract][Full Text] [Related]
4. FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination.
Shi S; Zhang Q; Zhang K; Chen W; Xie H; Pan S; Xue Z; You B; Zhao J; You Y
Cell Oncol (Dordr); 2024 Feb; 47(1):283-301. PubMed ID: 37782406
[TBL] [Abstract][Full Text] [Related]
5. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
[TBL] [Abstract][Full Text] [Related]
6. WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma.
Zhao Y; Li WF; Li QJ; He SW; He QM; Long LF; Liu N; Ma J
Oral Oncol; 2021 Nov; 122():105576. PubMed ID: 34689010
[TBL] [Abstract][Full Text] [Related]
7. HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagy.
Zhang Y; Pang C; Zhang C; Wang Y; Wang P; Chen Y; Wang J; Hu Y; Liu C; Liang H; Xie G; Ou J
Cell Mol Life Sci; 2023 Aug; 80(9):242. PubMed ID: 37552373
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
[TBL] [Abstract][Full Text] [Related]
9. Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.
Guo Y; Zhai J; Zhang J; Ni C; Zhou H
Med Sci Monit; 2019 Apr; 25():3161-3169. PubMed ID: 31034464
[TBL] [Abstract][Full Text] [Related]
10. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
[TBL] [Abstract][Full Text] [Related]
11. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
[TBL] [Abstract][Full Text] [Related]
12. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
[TBL] [Abstract][Full Text] [Related]
13. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
15. VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.
Chen L; Lin G; Chen K; Wan F; Liang R; Sun Y; Chen X; Zhu X
Sci Rep; 2020 Oct; 10(1):16328. PubMed ID: 33004943
[TBL] [Abstract][Full Text] [Related]
16. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of
Zhang J; Li YQ; Guo R; Wang YQ; Zhang PP; Tang XR; Wen X; Hong XH; Lei Y; He QM; Yang XJ; Sun Y; Ma J; Liu N
Cancer Res; 2019 Feb; 79(4):747-759. PubMed ID: 30573520
[TBL] [Abstract][Full Text] [Related]
18. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
19. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
